Weidi Yin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Weidi Yin has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Jin-Oh Hahn
Mechanical Engineering, University of Maryland, College Park, MD, 20742, USA
4 shared publications - Ali Tivay
Department of Mechanical Engineering, University of Maryland, USA
3 shared publications - Hosam K. Fathy
Department of Mechanical Engineering, University of Maryland at College Park, College Park, MD, USA
2 shared publications Drew X. Hohenhaus
Department of Mechanical Engineering, University of Maryland, USA
1 shared publication- Rajesh Rajamani
University of Minnesota, Twin Cities Minneapolis Minnesota USA
1 shared publication
Latest Publications
- 6 March 2025
- Published by Springer Nature in Journal of Clinical Monitoring and Computing
- Vol. 39 (3) , 541-558
Safe automation of interfering medical treatments via control barrier functions and reachability analysis: a fluid resuscitation-sedation-vasopressor infusion case study
Despite advances made toward the automation of medical treatments, existing work has predominantly focused on the automation of individual medical treatments while overlooking interferences between them. In our prior work, we developed an automation architecture to administer interfering medical treatments with safety, which (i) monitors internal physiological state of a patient using an extended Kalman filter, (ii) mediates medical treatments to bound the estimated internal state within a prescribed safe regime based on control barrier functions, and (iii) treats the patient to a prespecified treatment target through a number of intermediate targets derived from reachability analysis. The goal of this work was to investigate the scalability of this automation architecture in more complex and challenging medical treatment scenarios with a number of conflicts. Using a critical care resuscitation scenario including fluid resuscitation and intravenous sedative-vasopressor infusion, we examined if our automation architecture can achieve treatment goals while ascertaining the safety of internal state in a large number of diverse in silico patients. The results suggested that (i) the extended Kalman filter could continuously monitor a patient’s internal physiological state, (ii) the control barrier functions could mediate interfering medical treatments and protect patients against unsafe internal physiological state, and (iii) the reachability analysis could treat a patient as closely as possible to a treatment target while ensuring the safety of the patient’s internal physiological state, all despite complex and entangled conflicts between them. Our automation architecture may provide a viable means to autonomously de-conflict interfering medical treatments.
- 6 March 2025
- Published by Springer Nature in Journal of Clinical Monitoring and Computing
- Vol. 39 (3) , 541-558
Safe automation of interfering medical treatments via control barrier functions and reachability analysis: a fluid resuscitation-sedation-vasopressor infusion case study
Despite advances made toward the automation of medical treatments, existing work has predominantly focused on the automation of individual medical treatments while overlooking interferences between them. In our prior work, we developed an automation architecture to administer interfering medical treatments with safety, which (i) monitors internal physiological state of a patient using an extended Kalman filter, (ii) mediates medical treatments to bound the estimated internal state within a prescribed safe regime based on control barrier functions, and (iii) treats the patient to a prespecified treatment target through a number of intermediate targets derived from reachability analysis. The goal of this work was to investigate the scalability of this automation architecture in more complex and challenging medical treatment scenarios with a number of conflicts. Using a critical care resuscitation scenario including fluid resuscitation and intravenous sedative-vasopressor infusion, we examined if our automation architecture can achieve treatment goals while ascertaining the safety of internal state in a large number of diverse in silico patients. The results suggested that (i) the extended Kalman filter could continuously monitor a patient’s internal physiological state, (ii) the control barrier functions could mediate interfering medical treatments and protect patients against unsafe internal physiological state, and (iii) the reachability analysis could treat a patient as closely as possible to a treatment target while ensuring the safety of the patient’s internal physiological state, all despite complex and entangled conflicts between them. Our automation architecture may provide a viable means to autonomously de-conflict interfering medical treatments.
- 18 November 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 72 (3) , 1121-1131
LMI-Enabled Absolutely Stabilizing PID Control of Pharmacological Systems for Closed-Loop Automated Intravenous Drug Administration
Objective: We developed a linear matrix inequality-enabled absolutely stabilizing proportional-integral-derivative control design approach for pharmacological systems applicable to intravenous drug administration. Methods: We developed a proportional-integral- derivative control design approach that does not require detailed knowledge of the dose-response relationship other than its sector bound. It repetitively solves a set of linear matrix inequalities, which encapsulate the Lyapunov stability conditions against unknown dose-response relationship, over a broad proportional-integral-derivative gain space. The linear matrix inequality-feasible proportional-integral-derivative gains guarantee the absolute stability of the closed-loop control system against unknown yet sector-bounded dose-response relationship. The proof-of-concept of the approach was shown in silico using intravenous propofol anesthesia as a practical case scenario. Results: The in silico evaluation results demonstrated the robustness and performance of the proportional-integral- derivative controllers designed with the proposed control design approach against unknown sector-bounded nonlinear dose-response relationship and parametric uncertainty in the plant dynamics. Conclusion: Pending follow-up development and extensive evaluation in various complex intravenous drug administration problems, the proposed approach may find applications in various closed-loop automated intravenous drug administration problems with complex and highly nonlinear dose-response relationships. Significance: The proposed control design approach provides a systematic way to absolutely stabilize pharmacological systems against unknown, nonlinear, and time- varying dose-response relationship, perhaps for the first time.
- 18 November 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 72 (3) , 1121-1131
LMI-Enabled Absolutely Stabilizing PID Control of Pharmacological Systems for Closed-Loop Automated Intravenous Drug Administration
Objective: We developed a linear matrix inequality-enabled absolutely stabilizing proportional-integral-derivative control design approach for pharmacological systems applicable to intravenous drug administration. Methods: We developed a proportional-integral- derivative control design approach that does not require detailed knowledge of the dose-response relationship other than its sector bound. It repetitively solves a set of linear matrix inequalities, which encapsulate the Lyapunov stability conditions against unknown dose-response relationship, over a broad proportional-integral-derivative gain space. The linear matrix inequality-feasible proportional-integral-derivative gains guarantee the absolute stability of the closed-loop control system against unknown yet sector-bounded dose-response relationship. The proof-of-concept of the approach was shown in silico using intravenous propofol anesthesia as a practical case scenario. Results: The in silico evaluation results demonstrated the robustness and performance of the proportional-integral- derivative controllers designed with the proposed control design approach against unknown sector-bounded nonlinear dose-response relationship and parametric uncertainty in the plant dynamics. Conclusion: Pending follow-up development and extensive evaluation in various complex intravenous drug administration problems, the proposed approach may find applications in various closed-loop automated intravenous drug administration problems with complex and highly nonlinear dose-response relationships. Significance: The proposed control design approach provides a systematic way to absolutely stabilize pharmacological systems against unknown, nonlinear, and time- varying dose-response relationship, perhaps for the first time.
- 9 November 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Control Systems Letters
- Vol. 7, 709-714
Hemodynamic Safety Assurance in Closed-Loop Controlled Critical Care: Hemorrhage Resuscitation and Sedation Case Study
This letter presents a novel approach to assure hemodynamic safety in closed-loop controlled critical care. The approach is equipped with safety-preserving control based on control barrier functions to ensure the safety of hemodynamic state, hemodynamic monitoring to estimate hemodynamic state, and probabilistic recursive therapeutic target guidance to direct a patient as closely as possible to a prescribed therapeutic target along a desired trajectory. A notable advantage of the approach is that it can be augmented to single-input-single-output critical care control loops developed in isolation to guard hemodynamic safety against conflicts between them, providing a practical alternative to sophisticated multi-input-multi-output control loop design. The efficacy of the approach was examined in a hemorrhage resuscitation-intravenous sedation case study using realistic virtual patients. The approach as a whole assured the boundedness of hemodynamic state by reconciling conflicts between the two control loops. The recursive therapeutic target guidance directed patients to personalized reachable targets while maintaining the patients’ therapeutic responses near the desired therapeutic trajectory. The approach may serve as an effective means to reconcile multiple critical care control loops and assure holistic hemodynamic safety.
- 9 November 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Control Systems Letters
- Vol. 7, 709-714
Hemodynamic Safety Assurance in Closed-Loop Controlled Critical Care: Hemorrhage Resuscitation and Sedation Case Study
This letter presents a novel approach to assure hemodynamic safety in closed-loop controlled critical care. The approach is equipped with safety-preserving control based on control barrier functions to ensure the safety of hemodynamic state, hemodynamic monitoring to estimate hemodynamic state, and probabilistic recursive therapeutic target guidance to direct a patient as closely as possible to a prescribed therapeutic target along a desired trajectory. A notable advantage of the approach is that it can be augmented to single-input-single-output critical care control loops developed in isolation to guard hemodynamic safety against conflicts between them, providing a practical alternative to sophisticated multi-input-multi-output control loop design. The efficacy of the approach was examined in a hemorrhage resuscitation-intravenous sedation case study using realistic virtual patients. The approach as a whole assured the boundedness of hemodynamic state by reconciling conflicts between the two control loops. The recursive therapeutic target guidance directed patients to personalized reachable targets while maintaining the patients’ therapeutic responses near the desired therapeutic trajectory. The approach may serve as an effective means to reconcile multiple critical care control loops and assure holistic hemodynamic safety.
- 5 April 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Control Systems Letters
- Vol. 6, 2455-2460
Hemodynamic Monitoring via Model-Based Extended Kalman Filtering: Hemorrhage Resuscitation and Sedation Case Study
This letter investigates the potential of model-based extended Kalman filtering (EKF) for hemodynamic monitoring in a hemorrhage resuscitation-sedation case study. To the best of our knowledge, it may be the first model-based state estimation study conducted in the context of hemodynamic monitoring. Built upon a grey-box mathematical model with parametric uncertainty as process noise, the EKF can estimate cardiac output (CO) and total peripheral resistance (TPR) continuously from mean arterial pressure (AP) measurements against inter-individual physiological and pharmacological variability. Its unique practical strengths include: it does not require AP waveform as in existing AP-based pulse-contour CO (PCCO) monitors; and it can estimate CO and TPR with explicit account for the effect of sedative drugs. The efficacy of the EKF-based hemodynamic monitoring was evaluated based on a large number of plausible virtual patients generated using a collective inference algorithm, which demonstrated that it has significant advantage over open-loop pure prediction, and that its accuracy is comparable to PCCO.
- 5 April 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Control Systems Letters
- Vol. 6, 2455-2460
Hemodynamic Monitoring via Model-Based Extended Kalman Filtering: Hemorrhage Resuscitation and Sedation Case Study
This letter investigates the potential of model-based extended Kalman filtering (EKF) for hemodynamic monitoring in a hemorrhage resuscitation-sedation case study. To the best of our knowledge, it may be the first model-based state estimation study conducted in the context of hemodynamic monitoring. Built upon a grey-box mathematical model with parametric uncertainty as process noise, the EKF can estimate cardiac output (CO) and total peripheral resistance (TPR) continuously from mean arterial pressure (AP) measurements against inter-individual physiological and pharmacological variability. Its unique practical strengths include: it does not require AP waveform as in existing AP-based pulse-contour CO (PCCO) monitors; and it can estimate CO and TPR with explicit account for the effect of sedative drugs. The efficacy of the EKF-based hemodynamic monitoring was evaluated based on a large number of plausible virtual patients generated using a collective inference algorithm, which demonstrated that it has significant advantage over open-loop pure prediction, and that its accuracy is comparable to PCCO.